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Surveillance was conducted for three clinical syndromes (hemorrhagic fever, encephalitis, and hepatitis) in
Cambodian children admitted to the National Pediatric Hospital in Phnom Penh from July 1996 through
September 1998. Acute- and convalescent-phase sera, and cerebrospinal fluid, when applicable, under-
went diagnostic evaluation for infections with Dengue virus (DENV), Japanese encephalitis virus (JEV),
and Hepatitis A, B, C, and E viruses. Of 621 children admitted with hemorrhagic fever, 499 (80%) were
confirmed to have either primary or secondary DENV infection. DENV rates were as high as 10.6/100 hos-
pital admissions in September 1998. Of 50 children with clinical encephalitis, 9 (18%) had serologic evi-
dence of JEV infection. Forty-four children had clinical hepatitis, most (55%) due to Hepatitis A virus
(HAV). One patient had Hepatitis B virus, and no patients had hepatitis C or E. This study identified a large
number of children with vaccine-preventable diseases (JEV and HAV). 
nfectious diseases continue to pose a major threat to popu-
lations in developing countries in tropical regions. Dengue
is the most important arbovirus infection in Southeast Asia (1).
It is spread by the bite of the vector mosquito, Aedes aegypti,
and causes asymptomatic infection, mild to severe influenza-
like symptoms (dengue fever), and plasma leakage and hemor-
rhage, which are sometimes fatal (dengue hemorrhagic fever).
In 1995, Rathavuth et al. conducted 2 days of surveillance for
hemorrhagic fever in children admitted to the National Pediat-
ric Hospital (NPH) in Phnom Penh (2). Their findings of a
high frequency of secondary Dengue virus (DENV) infection,
a low mean age of admission, and the presence of all four den-
gue serotypes suggested that dengue was highly endemic in
Cambodia. 
Bacterial, viral, fungal, and parasitic agents are all causes
of encephalitis or encephalopathy in children in Southeast
Asia. Tsai reported that the main causes of encephalitis in rural
Asia included tuberculosis, typhoid fever, cerebral malaria,
and viruses such as DENV, herpes simplex, measles, Enterovi-
rus, and HIV (3). Few reports have been published about the
incidence or possible causes of encephalitis in Cambodian
children. In a report by Sunara et al., surveillance at two pedi-
atric hospitals in Phnom Penh from 1990 through 1994
showed >300 cases of acute encephalitis in children (4). While
the cause for many of these cases was suspected to be Japa-
nese encephalitis virus (JEV), laboratory confirmation was
lacking. 
Only one report has discussed the prevalence of markers
for Hepatitis viruses A, B, and C (HAV, HBV, HCV), in Cam-
bodia. In 1991, Thuring et al. conducted a serologic study for
markers of viral hepatitides and HIV in Takeo, a southern
province (5). In that study, adults and children, both healthy
and those ill with liver or kidney disease, were examined.
HAV was the most frequent cause of acute hepatitis in these
children, occurring in 11 (32%) of 34 pediatric patients. Ongo-
ing infection with HBV accounted for 18%, and one child
tested positive for HCV-specific antibody. That study did not
screen for Hepatitis E virus (HEV) infection. 
Our study was undertaken to characterize the extent of dis-
ease in Cambodian children, specifically for the following
three syndromes: hemorrhagic fever (HF), encephalitis, and
hepatitis.
Materials and Methods
Surveillance was conducted at NPH in Phnom Penh. This
hospital, one of two pediatric referral hospitals in Cambodia,
serves a population of approximately 2.7 million children ages
<14. Enrolled in this study were children admitted with any of
the following clinical signs: HF (fever, headache, or rash, and
on physical examination, a positive tourniquet test, ascites,
pleural effusion bleeding, or shock); encephalitis (headache,
fever, or neck stiffness, and alteration of consciousness or
focal neurologic signs); and hepatitis (lethargy, anorexia, nau-
sea or vomiting, abdominal pain, hepatomegaly, scleral ict-
erus, or jaundice). Case definitions were kept broad to capture
as many cases as possible.
On the basis of published criteria from the World Health
Organization, cases of DHF were classified into one of four
grades of severity. Grade 1 includes fever with nonspecific
symptoms; the only hemorrhagic manifestation is a positive
tourniquet test, easy bruising, or both. Grade 2 includes Grade
1 manifestations plus spontaneous bleeding (usually skin hem-
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orrhages). Grade 3 includes circulatory failure (rapid, weak
pulse, hypotension) and cold, clammy skin. Grade 4 is mani-
fested by profound shock with undetectable blood pressure or
pulse. The last two grades are considered to be dengue shock
syndrome (DSS).
Sera were collected on the day of admission, at the time of
discharge, and, in some cases, on follow-up exam. However,
due to the nature of the population, a follow-up visit was not
always possible, and therefore diagnosis relied on only an
admission and discharge sample. Sera were stored at -70°C
until transported to the Armed Forces Research Institute of
Medical Sciences in Bangkok, Thailand, on dry ice. Clinical
criteria for admission diagnosis directed the subsequent diag-
nostic workup. All DHF and encephalitis cases were tested for
both JEV and DENV. Sera were tested for immunoglobulin
(Ig) G and IgM antibody against DENV and JEV by use of an
antibody-capture enzyme-linked immunoassay (EIA) and pre-
viously published criteria of acute and primary or secondary
dengue (6). Virus isolation was attempted with acute-phase
serum specimens, as previously described (7). 
Sera were screened for IgM antibody to HAV, IgM anti-
body to hepatitis B core antigen (HbcAg), hepatitis B surface
antigen (HbsAg), and total Ig to HCV by using commercially
available kits (HAVAB-EIA, Corzyme-M, AUZYME Mono-
clonal, and HCV EIA Third Generation; Abbott Laboratories,
Abbott Park, IL). Assays were performed as recommended by
the manufacturer.
All samples were tested for total Ig and IgM to HEV by an
indirect second-generation EIA developed at the Department
of Virus Diseases, Walter Reed Army Institute of Research.
The assay quantifies total Ig and IgM reactive with recombi-
nant HEV capsid protein expressed using a baculovirus system
expressed in U/mL (8). To control interassay variation, all
specimens were tested in duplicate wells, with all specimens
from a single patient tested together on the same plate. A
patient was considered to have HEV infection if there was
virologic (HEV RNA positive) or serologic (IgM >100 U/mL,
total Ig >500 U/mL) evidence of acute infection.
Statistics
All statistical procedures were performed by using SPSS
for Windows, Version 10.0 (SPSS Inc., Chicago, IL). Fisher’s
exact test (two-tailed) was used to determine significant differ-
ence in the number of boys with encephalitis and diagnosed as
having JEV compared with girls with the same syndrome and
final diagnosis.
Results
Figure 1 shows the rates of HF, encephalitis, and hepatitis
per 100 hospital admissions, by month and year. From July
1996 through September 1998, 621 children were admitted
with a diagnosis of HF (Table 1). Of those, 495 were con-
firmed to have a secondary DENV infection by serologic tests;
14 had primary dengue. Figure 2 illustrates the number of con-
firmed DENV patients compared with the total number of
patients with HF. 
The severity of DHF can be classified into four grades
based on two pathophysiologic findings: hemorrhage and
shock. In this study, 41 of the 509 total confirmed dengue
patients had DHF Grade 1; 145 patients had DHF Grade 2; 180
patients had DHF Grade 3; and 29 patients had DHF Grade 4.
Of the 75 samples tested, 22 were polymerase chain reac-
tion (PCR)-positive for virus. DENV-2 was isolated from 14
samples, DENV-3 from seven samples, and DENV-4 from one
sample. All three serotypes were found in children living in
Phnom Penh. DENV-2 and -3 were found in Kampong Speu
Figure 1. Admission rates by disease syndrome and month, National
Pediatric Hospital, 1996–1998.*
*Rates are given as number of cases per 100 hospital admissions.
Table 1. Characteristics of pediatric patients with clinical hemorrhagic 
fever, encephalitis, or hepatitis, National Pediatric Hospital, Phnom 
Penh, Cambodia, July 1996–September 1998a 
Syndrome
Total no. 
of cases Males Females
Mean age 
(range) Outcome
Total 
hemorrhagic fever
621 288 332 7 yrs 
(5 mo-15 yrs)
11b
   Secondary 
   dengue
495 222 272 7 yrs 
(8 mo-15 yrs)
4b
   Primary dengue 14 8 6 4 yrs 
(5 mo-9 yrs)
—
Total encephalitis 50 15 35 4 yrs 
(3 mo-14 yrs)
17b 
12c
   JE 9 6 3 6 yrs 
(3-10 yrs)
2b
2c
Total hepatitis 44 21 23 6 yrs 
(2 mo-14 yrs)
—
   Hepatitis A 24 12 12 5 yrs 
(2 mo-9 yrs)
—
   Hepatitis B 1 1 0 10 yrs —
aTotal number of hospital admissions during this period was 16,492 children.
bDeaths.
cDisabled.
JE, Japanese encephalitis; —, all recovered.Emerging Infectious Diseases  •  Vol. 8, No. 5, May 2002 487
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and Kampong Cham. The other provinces appeared to have
only one circulating dengue serotype, based on the small num-
ber of positive samples.
During this same period, 50 children were admitted to
NPH with a diagnosis of encephalitis; 9 (18%) were due to
JEV (Table 1) and 2 to acute secondary dengue infection.
There was no evidence of concurrent infections. Figure 3 illus-
trates the number of cases of JEV, by month and year, com-
pared with the total encephalitis cases. While over twice as
many girls as boys had this syndrome, significantly more boys
were diagnosed with JEV infection (p=0.015). The final out-
come for children seen at NPH with encephalitis was poor:
death or disability occurred in 29 (58%) of the children.
Forty-four children were admitted with a diagnosis of hep-
atitis. Twenty-four cases were confirmed to be due to acute
HAV infection on the basis of elevated HAV IgM antibodies
(Table 1). One patient had serologic evidence of acute hepatitis
B, and no serologic evidence for HCV or HEV infections. Fig-
ure 4 illustrates the number of HAV patients compared with
the total number of patients admitted to NPH with a clinical
diagnosis of hepatitis. Of the 24 children hospitalized with
hepatitis A, 17 (71%) had onset in July, August, and Septem-
ber. Most children admitted to NPH came from Phnom Penh
(339 patients) or its adjacent province, Kandal (146 patients).
Table 2 shows the distribution of inpatients by province and
syndrome on admission. 
Discussion
This surveillance was undertaken to characterize the extent
of disease in Cambodian children with respect to three specific
syndromes: hemorrhagic fever, encephalitis, and hepatitis. To
our knowledge, this is the first such study conducted in Cam-
bodia. As in other Southeast Asian countries, DHF accounted
for a large percentage of hospitalizations and deaths of Cam-
bodian children. Dengue was confirmed in 82% of children
admitted to NPH with symptoms that suggested dengue fever.
Serologic results for the remaining 112 HF cases suggested
DENV infection in most instances, but lack of a convalescent-
phase sample prevented definitive diagnosis. DHF has been
reported as a leading cause of hospitalization and death of chil-
dren throughout Asia in 1998 (9). Our surveillance shows that
in August and September 1998, the hospitalization rate for
children with HF exceeded 10 per 100 hospital admissions. 
Similarly, Japanese encephalitis has been reported to occur
in nearly every country in Asia (10). While the disease is pre-
sumed to be endemic in Cambodia, no laboratory-confirmed
data on disease frequency have been published until now. Dur-
ing this 2-year study, 18% of children admitted to NPH with
encephalitis had JEV infection. Similar to reports elsewhere
(11), more cases of JEV infection occurred in boys than in
girls (six versus three, respectively). Transmission of disease is
usually seasonal, from late summer to early fall. In our study,
67% of cases were reported from May to October; the remain-
der occurred in January or February. 
HAV infection is highly endemic in developing countries
that lack adequate clean water and have poor sanitary condi-
tions (12). According to the 1998 Cambodian General Popula-
tion Census, only 29% of the population has access to safe
water (range 23.7%-60.3%) (13). In poorer countries, most
children develop antibodies to HAV by age 10. A seropreva-
lence study conducted on 200 healthy Cambodian children
from 1990 through 1991 showed that 97% were positive for
anti-HAV IgG by 15 years of age (5). While hepatitis A is
Figure 2. Cases of hemorrhagic fever (HF), secondary and primary
dengue, National Pediatric Hospital, 1996–1998
Figure 3. Total number of cases of encephalitis versus Japanese
encephalitis, National Pediatric Hospital, 1996–1998.
Figure 4. Total number of cases of hepatitis versus hepatitis A, National
Pediatric Hospital, 1996–1998.RESEARCH
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largely considered a subclinical infection in children in Thur-
ing’s study, it accounted for 32% of acute hepatitis in hospital-
ized children in our study; hepatitis A accounted for 55% of
the pediatric patients hospitalized with suspected hepatitis.
One (2%) of 44 children showed evidence of ongoing
HBV infection. This contrasts with Thuring’s earlier study, in
which 18% of children with acute hepatitis were actively
infected with HBV (HbsAg positive). However, similar to
Thuring’s study, we saw no evidence of HCV in this popula-
tion. 
No indication of acute hepatitis E was found in our study,
nor did any of the children admitted to NPH with hepatitis
have evidence of prior exposure to HEV. Similar to hepatitis
A, hepatitis E is common in countries that lack adequate clean
water and in which general sanitation is poor. In Southeast
Asia, epidemics of HEV have been reported in Myanmar, Viet-
nam, and Indonesia (14). In most disease-endemic areas, up to
5% of the children are positive for anti-HEV antibodies. While
clinical attack rates of hepatitis E are reported to be highest in
young adults (15-40 years), a recent report from India noted
anti-HEV antibodies in >60% of children <5 years old (15).
Cambodia is surrounded by countries (except Thailand) that
are endemic for HEV; therefore, the total lack of anti-HEV
IgG in this Cambodian population was unexpected.
Currently, Cambodian children are given BCG, polio, diph-
theria-tetanus-pertussis, and measles vaccines, although cover-
age varies throughout the country. Instituting childhood HAV
immunizations could benefit countries that have shown a
decrease in age-related HAV seroprevalence concomitant with
improved socioeconomic development (16,17). While the
seroprevalence for HAV in Thuring’s 1991 study approached
100% in children by age 15, no HAV seroprevalence data have
been gathered since then. Further studies are warranted to
determine if additional vaccines, such as those for HAV and
JEV, should be added to the nation’s immunization program. 
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